Literature DB >> 1719412

Evaluation of secondary nitroalkanes, their nitronates, primary nitroalkanes, nitrocarbinols, and other aliphatic nitro compounds in the Ames Salmonella assay.

C C Conaway1, N S Hussain, B M Way, E S Fiala.   

Abstract

The secondary nitroalkanes 2-nitropropane, 2-nitrobutane, 3-nitropentane and nitrocyclopentane, as well as their anionic forms (nitronates); the primary nitroalkanes 1-nitropropane, 1-nitrobutane, and 1-nitropentane and their respective nitronates; the nitrocarbinols 2-nitro-1-propanol, 2-nitro-1-butanol, 3-nitro-2-butanol, and 3-nitro-2-pentanol and their respective nitronates; 2-methyl-2-nitropropane, and 2-nitroso-2-nitropropane were tested in the Ames Salmonella assay using strains TA98, TA100 and TA102. Nitronates of the secondary nitroalkanes 2-nitropropane, 2-nitrobutane, 3-nitropentane, and nitrocyclopentane were significantly mutagenic in Salmonella strains TA100 and TA102 at 10-80 mumoles/plate, but the parent compounds were mutagenic at only a single dose level or were not mutagenic at all in the same dose range. The primary nitroalkanes and the nitrocarbinols were not mutagenic, or only marginally so, at the concentrations tested. The nitronates of the primary nitroalkanes and the nitrocarbinols reprotonated too rapidly under the conditions of the assay for adequate evaluation of mutagenicity. 2-Methyl-2-nitropropane was not mutagenic in strains TA100 and TA102; 2-nitroso-2-nitropropane was also not mutagenic in strains TA100 and TA102, but induced an equivocal mutagenic response in TA98. The positive Salmonella mutation data for the nitronates of the secondary nitroalkanes studied correlate very well with the very slow rate of reprotonation of secondary nitroalkane nitronates at pH 7.7 (Conaway et al. (1991) Cancer Res., 51, 3143), and provide further evidence that nitronates of secondary nitroalkanes, rather than the neutral parent forms with which they may be in equilibrium, are the more proximate mutagenic species.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1719412     DOI: 10.1016/0165-1218(91)90068-w

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  4 in total

1.  Initial studies using aliphatic beta-nitro alcohols for therapeutic corneal cross-linking.

Authors:  David C Paik; Quan Wen; Richard E Braunstein; Suzanna Airiani; Stephen L Trokel
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-10-03       Impact factor: 4.799

2.  Mechanistic and Catalytic Studies of β-Nitroalcohol Crosslinking with Polyamine.

Authors:  Xia Li; Yongjun Li; Yi Rao; Marissa R Solomon; David C Paik; Nicholas J Turro
Journal:  J Appl Polym Sci       Date:  2013-06-15       Impact factor: 3.125

3.  Aliphatic β-nitroalcohols for therapeutic corneoscleral cross-linking: corneal permeability considerations.

Authors:  Quan Wen; Stephen L Trokel; MiJung Kim; David C Paik
Journal:  Cornea       Date:  2013-02       Impact factor: 2.651

4.  Aliphatic beta-nitroalcohols for therapeutic corneoscleral cross-linking: chemical mechanisms and higher order nitroalcohols.

Authors:  David C Paik; Marissa R Solomon; Quan Wen; Nicholas J Turro; Stephen L Trokel
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-09-24       Impact factor: 4.799

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.